Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by shawshank666on Nov 23, 2023 9:12am
117 Views
Post# 35749799

Market Call BNN Bloomberg Sept 3,2021

Market Call BNN Bloomberg Sept 3,2021Just for the fun of it I Googled Ventripoint and saw an interview with Robert McWhirter of Select Asset Management dated Sept 3, 2021 on Market Call, BNN Bloomberg. He talked about many things but what stood out was that fact that Ventipoint was supposed to start placing units in Chinese hospitals in the near future. Here we are over 2 years later and I haven't heard of any sales to Chinese hospitals. Maybe this will still happen in the future. Overall this McWhirter seemed pretty positive on Ventipoint back on Sept 3, 2021. At that time the stock was trading at 42 cents. I am wondering if he is still  positive on Ventipoint at 14 cents. Maybe one of the many reasons we are at 14 cents is the fact that we never sold any units to China and also you don't hear about any potential sales to China. Has anybody heard anything about Ventipoint talking with China. 
<< Previous
Bullboard Posts
Next >>